Post-earnings recap
Reported
Tue, May 4, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
IDEXX Labs reported a strong earnings per share, exceeding expectations significantly. However, the stock fell by 4.18% in reaction, likely due to the lack of revenue details and guidance. Investors may be concerned about ongoing supply chain challenges despite the positive EPS surprise.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.35 | N/A | +36.79% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook for the veterinary market despite current supply chain issues. They emphasized their commitment to innovation and customer service.
Management highlighted strong demand in their core veterinary diagnostics segment.
They noted ongoing challenges in supply chain but expressed confidence in long-term growth.